Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases

BACKGROUND: Hemolytic anemia is a rare but reported side effect of intravenous immunoglobulin (IVIG) therapy. The risk of significant hemolysis appears greater in those patients who receive high dose IVIG. The etiology is multifactorial but may relate to the quantity of blood group antibodies admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Berard, Roberta, Whittemore, Blair, Scuccimarri, Rosie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353234/
https://www.ncbi.nlm.nih.gov/pubmed/22507284
http://dx.doi.org/10.1186/1546-0096-10-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353234/
https://www.ncbi.nlm.nih.gov/pubmed/22507284
http://dx.doi.org/10.1186/1546-0096-10-10

Ejemplares similares